United States · FDA National Drug Code directory
Naproxen Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72036-145_58dec06b-7673-bfe7-e063-6294a90ac51a
- Product NDC
- 72036-145
- Form
- TABLET, COATED
- Composition / generic term
- NAPROXEN SODIUM
- Labeler
- Harris Teeter
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20111201
- Source listing expiry
- 20271231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (72036-145-01) / 24 TABLET, COATED in 1 BOTTLE, PLASTIC · 72036-145-01
- 1 BOTTLE, PLASTIC in 1 CARTON (72036-145-02) / 50 TABLET, COATED in 1 BOTTLE, PLASTIC · 72036-145-02
- 1 BOTTLE, PLASTIC in 1 CARTON (72036-145-03) / 100 TABLET, COATED in 1 BOTTLE, PLASTIC · 72036-145-03
- 200 TABLET, COATED in 1 BOTTLE, PLASTIC (72036-145-08) · 72036-145-08
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →